Lin, Shih-Kai KevinShih-Kai KevinLinHSI-CHUNG CHENChen, Chun-HsinChun-HsinChenI-MING CHENLu, Mong-LiangMong-LiangLuHsu, Cheng-DienCheng-DienHsuChiu, Yi-HangYi-HangChiuTSUNG-YANG WANGChen, Hui-MeiHui-MeiChenChung, Yu-Chu EllaYu-Chu EllaChungPO-HSIU KUO2024-01-292024-01-292024-01-0101650327https://scholars.lib.ntu.edu.tw/handle/123456789/639138Antidepressants, specifically selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), are commonly prescribed for depression treatment. Animal studies have shown that antidepressants can influence gut microbiota composition and specific bacterial taxa. We aimed to investigate the association between antidepressant use and human gut microbiota composition and functional pathway.enAntidepressants; Depression; Gut microbiome; Selective serotonin reuptake inhibitors; Serotonin-norepinephrine reuptake inhibitors[SDGs]SDG3Exploring the human gut microbiota targets in relation to the use of contemporary antidepressantsjournal article10.1016/j.jad.2023.10.016378209622-s2.0-85174718248https://api.elsevier.com/content/abstract/scopus_id/85174718248